Not applicableStudy completedNCT05894525
What this trial is testing
Post-Marketing Safety Study in Japan in Participants With High Risk of Severe Exacerbation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine
Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 8,844